OPEN American journal of obstetrics and gynecology | 22 Feb 2017
BT Schjoldager, E Mikkelsen, MR Lykke, J Præst, AM Hvas, L Heslet, NJ Secher, JD Salvig and N Uldbjerg
During cesarean delivery in patients with placenta previa, hemorrhaging after removal of the placenta is often challenging. In this condition, the extraordinarily high concentration of tissue factor at the placenta site may constitute a principal of treatment as it activates coagulation very effectively. The presumption, however, is that tissue factor is bound to activated factor VII (FVIIa).
* Data courtesy of Altmetric.com